Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

 1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size by Donor Type

  2.3.2 Market Size by Type of Transplant

  2.3.3 Market Size by End User

  2.3.4 Market Size by Immunosuppressive Drug Class

 2.3.5 Market Size by Organ Preservation Method

 2.4 Market Share & Bps Analysis by Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

   3.4.1 Donor Identification, Evaluation & Organ Procurement

   3.4.2 Organ Allocation Networks & Transplant Coordination Organizations

   3.4.3 Organ Preservation, Packaging & Transportation

   3.4.4 Transplant Diagnostics & Histocompatibility Testing

   3.4.5 Kidney Transplant Centers & Surgical Service Providers

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

4.1 Transplant Activity & Donor Utilization Metrics

4.1.1 Annual kidney transplant volume and growth (%) segmented by living donor and deceased donor procedures.

4.1.2 Deceased donor kidney utilization rate (%) among kidneys recovered for transplantation, including non-use rates by donor age and organ quality.

4.1.3 Living donor contribution (%) to total kidney transplant procedures across major national markets.

4.2 Waiting List & Organ Access Metrics

4.2.1 Kidney transplant waiting list size and annual additions relative to completed transplant procedures.

4.2.2 Median waiting time (months or years) by blood group, donor type, geographic region, and patient priority category.

4.2.3 Waitlist mortality rate (deaths per 100 patient-years) and removal rate among candidates awaiting kidney transplantation.

4.3 Graft Performance & Patient Outcome Metrics

4.3.1 Patient and graft survival rates (%) at one, three, and five years after transplantation, segmented by donor type.

4.3.2 Delayed graft function incidence (%) following deceased donor and living donor kidney transplantation.

4.3.3 Acute rejection incidence (%) and graft failure rates across immunosuppressive treatment protocols and recipient risk profiles.

4.4 Transplant Economics & Clinical Resource Metrics

4.4.1 Average cost (USD) of kidney transplantation, including donor evaluation, organ procurement, surgery, hospitalization, and initial post-transplant care.

4.4.2 Post-transplant hospital length of stay (days) and readmission rate (%) by donor type and recipient complexity.

4.4.3 Long-term immunosuppressive therapy cost (USD per patient per year) and medication adherence rate (%) among kidney transplant recipients.

5. Kidney Transplant Market Segmental Analysis & Forecast, By Donor Type, 2022–2035, Value (USD Billion)

    5.1 Introduction

 5.2 Living Donor

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Deceased Donor

6. Kidney Transplant Market Segmental Analysis & Forecast, By Type of Transplant, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Non-Preemptive

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Preemptive

7. Kidney Transplant Market Segmental Analysis & Forecast, By Immunosuppressive Drug Class, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Calcineurin Inhibitors

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Antiproliferative Agents

 7.4 mTOR Inhibitors

 7.5 Corticosteroids

 7.6 Others

8. Kidney Transplant Market Segmental Analysis & Forecast, By Organ Preservation Method, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Static Cold Storage

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Hypothermic Machine Perfusion

 8.4 Normothermic Machine Perfusion

9. Kidney Transplant Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

         9.1 Introduction 

  9.2 Hospitals

   9.2.1 Key Trends 

   9.2.2 Market Size & Forecast, 2022–2035 

  9.3 Transplant Clinics

10. Kidney Transplant Market Segmental Analysis & Forecast, By Region, 2022–2035, Value (USD Billion)

 10.1 Introduction

 10.2 North America

  10.2.1 Key Trends

  10.2.2 Kidney Transplant Market Size & Forecast, By Donor Type, 2022–2035

  10.2.3 Kidney Transplant Market Size & Forecast, By Type of Transplant, 2022–2035

  10.2.4 Kidney Transplant Market Size & Forecast, By Immunosuppressive Drug Class, 2022–2035

  10.2.5 Kidney Transplant Market Size & Forecast, By Organ Preservation Method, 2022–2035

  10.2.6 Kidney Transplant Market Size & Forecast, By End User, 2022–2035

  10.2.7 Kidney Transplant Market Size & Forecast, By Country, 2022–2035

   10.2.7.1 USA

   10.2.7.2 Canada

10.3 Europe

 10.3.1 Key Trends

 10.3.2 Kidney Transplant Market Size & Forecast, By Donor Type, 2022–2035

 10.3.3 Kidney Transplant Market Size & Forecast, By Type of Transplant, 2022–2035

 10.3.4 Kidney Transplant Market Size & Forecast, By Immunosuppressive Drug Class, 2022–2035

 10.3.5 Kidney Transplant Market Size & Forecast, By Organ Preservation Method, 2022–2035

 10.3.6 Kidney Transplant Market Size & Forecast, By End User, 2022–2035

 10.3.7 Kidney Transplant Market Size & Forecast, By Country, 2022–2035

  10.3.7.1 Germany

  10.3.7.2 UK

  10.3.7.3 France

  10.3.7.4 Italy

  10.3.7.5 Spain

  10.3.7.6 Russia

  10.3.7.7 Poland

  10.3.7.8 Rest of Europe

10.4 Asia-Pacific

 10.4.1 Key Trends

 10.4.2 Kidney Transplant Market Size & Forecast, By Donor Type, 2022–2035

 10.4.3 Kidney Transplant Market Size & Forecast, By Type of Transplant, 2022–2035

 10.4.4 Kidney Transplant Market Size & Forecast, By Immunosuppressive Drug Class, 2022–2035

 10.4.5 Kidney Transplant Market Size & Forecast, By Organ Preservation Method, 2022–2035

 10.4.6 Kidney Transplant Market Size & Forecast, By End User, 2022–2035

 10.4.7 Kidney Transplant Market Size & Forecast, By Country, 2022–2035

  10.4.7.1 China

  10.4.7.2 India

  10.4.7.3 Japan

  10.4.7.4 South Korea

  10.4.7.5 Australia

  10.4.7.6 ASEAN Countries

  10.4.7.7 Rest of Asia-Pacific

10.5 Latin America

 10.5.1 Key Trends

 10.5.2 Kidney Transplant Market Size & Forecast, By Donor Type, 2022–2035

 10.5.3 Kidney Transplant Market Size & Forecast, By Type of Transplant, 2022–2035

 10.5.4 Kidney Transplant Market Size & Forecast, By Immunosuppressive Drug Class, 2022–2035

 10.5.5 Kidney Transplant Market Size & Forecast, By Organ Preservation Method, 2022–2035

 10.5.6 Kidney Transplant Market Size & Forecast, By End User, 2022–2035

 10.5.7 Kidney Transplant Market Size & Forecast, By Country, 2022–2035

  10.5.7.1 Brazil

  10.5.7.2 Argentina

  10.5.7.3 Mexico

  10.5.7.4 Colombia

  10.5.7.5 Rest of Latin America

10.6 Middle East & Africa

 10.6.1 Key Trends

 10.6.2 Kidney Transplant Market Size & Forecast, By Donor Type, 2022–2035

 10.6.3 Kidney Transplant Market Size & Forecast, By Type of Transplant, 2022–2035

 10.6.4 Kidney Transplant Market Size & Forecast, By Immunosuppressive Drug Class, 2022–2035

 10.6.5 Kidney Transplant Market Size & Forecast, By Organ Preservation Method, 2022–2035

 10.6.6 Kidney Transplant Market Size & Forecast, By End User, 2022–2035

 10.6.7 Kidney Transplant Market Size & Forecast, By Country, 2022–2035

  10.6.7.1 UAE

  10.6.7.2 Saudi Arabia

  10.6.7.3 Qatar

  10.6.7.4 South Africa

  10.6.7.5 Rest of Middle East & Africa

11. Competitive Landscape

 11.1 Key Players' Positioning

 11.2 Competitive Developments

  11.2.1 Key Strategies Adopted (%), By Key Players, 2025

  11.2.2 Year-Wise Strategies & Development, 2022 – 2025

  11.2.3 Number Of Strategies Adopted By Key Players, 2025

 11.3 Market Share Analysis, 2025

 11.4 Product/Service & Application Benchmarking

  11.4.1 Product/Service Specifications & Features By Key Players

  11.4.2 Product/Service Heatmap By Key Players

  11.4.3 Application Heatmap By Key Players

 11.5 Industry Start-Up & Innovation Landscape

11.6 Key Company Profiles

11.6.1 Novartis AG

11.6.1.1 Company Overview & Snapshot

11.6.1.2 Product/Service Portfolio

11.6.1.3 Key Company Financials

11.6.1.4 SWOT Analysis

11.6.2 Astellas Pharma Inc.

11.6.3 Sanofi

11.6.4 Pfizer Inc.

11.6.5 F. Hoffmann-La Roche Ltd

11.6.6 Veloxis Pharmaceuticals

11.6.7 Bristol-Myers Squibb Company

11.6.8 Thermo Fisher Scientific Inc.

11.6.9 BioLife Solutions, Inc.

11.6.10 TransMedics Group, Inc.

11.6.11 Terumo Corporation (OrganOx)

11.6.12 XVIVO Perfusion AB

11.6.13 Dr. Franz Köhler Chemie GmbH

11.6.14 Teva Pharmaceutical Industries Ltd.

11.6.15 Bio-Rad Laboratories, Inc.

11.6.16 Immucor, Inc.

11.6.17 Paragonix Technologies

11.6.18 Organ Recovery Systems

11.6.19 Bridge to Life Ltd.

11.6.20 CareDx, Inc.

12. Analyst Recommendations

 12.1 SNS Insider Opportunity Map

 12.2 Industry Low-Hanging Fruit Assessment

 12.3 Market Entry & Growth Strategy

 12.4 Analyst Viewpoint & Suggestions On Market Growth

13. Assumptions

14. Disclaimer

15. Appendix

 15.1 List Of Tables

 15.2 List Of Figures